Cargando…
Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1
The dire prognosis of pancreatic cancer has not markedly improved during past decades. The present study was carried out to explore the effect of Qingyihuaji formula (QYHJ) on inhibiting pancreatic cancer and prolonging survival in related Notch signaling pathway. Proliferation of pancreatic cancer...
Autores principales: | Xu, Yanli, Xu, Shan, Cai, Yueqin, Liu, Luming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691523/ https://www.ncbi.nlm.nih.gov/pubmed/26783407 http://dx.doi.org/10.1155/2015/145016 |
Ejemplares similares
-
Retracted: Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1
por: Alternative Medicine, Evidence-Based Complementary and
Publicado: (2021) -
Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells
por: Gao, Song, et al.
Publicado: (2016) -
Expression of HES and HEY genes in infantile hemangiomas
por: Adepoju, Omotinuwe, et al.
Publicado: (2011) -
Hey2 functions in parallel with Hes1 and Hes5 for mammalian auditory sensory organ development
por: Li, Shuangding, et al.
Publicado: (2008) -
History of a prolific family: the Hes/Hey-related genes of the annelid Platynereis
por: Gazave, Eve, et al.
Publicado: (2014)